Sathyanarayanan Sriram 4
4 · Codiak BioSciences, Inc. · Filed Jan 26, 2023
Insider Transaction Report
Form 4
Sathyanarayanan Sriram
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-24+140,000→ 140,000 totalExercise: $0.74Exp: 2033-01-23→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 24, 2024, with the remainder vesting in 12 equal quarterly installments thereafter.